Concepedia

Jude Owiredu

JO

Statistics

Publications

5

Citations

224

H-Index

5

Active since

2016

Affiliations

Beth Israel Deaconess Medical Center(Current)

University of Massachusetts Boston

Cornell University

Princess Margaret Cancer Centre

Harvard University

Jude Owiredu is an author at Beth Israel Deaconess Medical Center specializing in prostate cancer, molecular oncology, and molecular biology.

ORCID

Publications per year

2016–2024

5

Publications

5

Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer

Shuai Gao, Sujun Chen, Dong Han et al. · Nature Genetics · 2020 · 124 citations · Full text

, , +14

Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs

Dong Han, Maryam Labaf, Yawei Zhao et al. · Journal of Clinical Investigation · 2024 · 41 citations · Full text

, , +17

ZBTB7A Mediates the Transcriptional Repression Activity of the Androgen Receptor in Prostate Cancer

Sujun Chen, Wanting Han, Shuai Gao et al. · Cancer Research · 2019 · 37 citations · Full text

, , +16

A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer

Dong Han, Shuai Gao, Kevin Valencia et al. · Oncotarget · 2016 · 12 citations · Full text

, , +17

Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate

Xuanrong Chen, Michael A. Augello, Deli Liu et al. · Nature Communications · 2024 · 10 citations · Full text

, , +17

1–5 of 5